Clover Health Investments (CLOV) Tops Q1 EPS by 2c ; Offers Guidance

Clover Health Investments (NASDAQ: CLOV) reported Q1 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $346.9 million versus the consensus estimate of $323.79 million.

GUIDANCE:

Clover Health Investments sees FY2024 revenue of $1.3-1.35 billion, versus the consensus of $1.27 billion.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Limoneira (LMNR) Misses Q2 EPS by 8c, Beats on Revenue
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00